Pfizer, Moderna and J&J face shareholder pressure to broaden covid-19 vaccine access
Socially conscious investors have added resolutions to annual proxy ballots asking the companies to make shots more available to poorer countries27-03-2022
27-03-2022
Covid: China says vaccine makers upgraded shots to fight Omicron
Early lab studies have shown inactivated vaccines developed by Chinese companies Sinovac and Sinopharm elicited less protective antibodies against the omicron variant than mRNA vaccines from Pfizer19-03-2022
Moderna seeks FDA authorization for 4th dose of Covid vaccine shot
Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults. The request is broader than rival pharmaceutical company Pfizer's request earlier this week for the regulator to approve a booster shot for all seniors. In a press release, the company said its request for approval for all adults was made to provide flexibility to the Centers for Disease Control and Prevention and medical providers to determine the appropriate use of a second booster dose of the mRNA vaccine, including for those at higher risk of COVID-19 due to age or comorbidities." U.S. officials have been laying the groundwork to deliver additional booster doses to shore up the vaccines' protection against serious disease and death from COVID-19. The White House has been sounding the alarm that it needs Congress to urgently approve more funding for the federal government to secure more doses of the COVID-19 vaccines, either fo18-03-2022
Over 30 companies worldwide to start producing Pfizer's COVID pill
None of the companies that make COVID-19 vaccines have so far agreed to work with the group to allow other manufacturers to make their shots.17-03-2022
PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received requests for issue of duplicate Share Certificate(s) from the Shareholder(s).16-03-2022
Pfizer seeking authorisation for 4th Covid dose for seniors: Report
Drugmaker Pfizer is expected to request authorisation this week for an additional Covid-19 booster dose for seniors, according to a person familiar with the matter.16-03-2022
Pfizer-BioNTech vax greatly reduces Omicron infection risk among kids: CDC
Two doses of Pfizer-BioNTech Covid-19 vaccine greatly reduced the risk of Omicron infection among children aged five to 15, according to a study published by the US CDC.12-03-2022
Pfizer starts testing its covid-19 pill in children
Drugmaker expects results from its study of Paxlovid in high-risk children by end of year09-03-2022
EMA says not concerned by New York state data on Pfizer/BioNTech vaccine
"This study somehow showed lower protection from symptomatic COVID-19 but it is still within the frame of the level of protection that we are seeing overall with the vaccines that we have against Omicron and after a primary series," EMA's head of vaccines strategy, Marco Cavaleri, said.03-03-2022
Pfizer Covid vaccine less effective kids aged 5-11 against Omicron: Study
The study examined Pfizer vaccine effectiveness from December 13, 2021 to January 30, 2022, among 852,384 fully-vaccinated children 12-17 years and 365,502 children 5-11 years01-03-2022